Switchboard Buys Livara; Bessent vs. Fed Rocks Bond Markets
Switchboard Health acquires Livara for MSK care plus a $5M raise, as Treasury-Fed tensions and Nvidia earnings rattle global markets.
This week in brief
- Healthcare Practice & Business Deals: One small-to-medium healthcare deal emerged from this week’s news flow.
- Global Markets & Macro: Markets are navigating a tense mix of Fed policy uncertainty, Treasury intervention debate, and a pivotal earnings event.
Healthcare Practice & Business Deals
One small-to-medium healthcare deal emerged from this week’s news flow. The broader candidate list was dominated by regulatory, clinical, and workforce stories. None of those were qualifying named transactions.
Switchboard Health Acquires Livara Health — $5M Funding Round Secured: Switchboard Health has acquired Livara Health, a value-based musculoskeletal (MSK) care company. At the same time, it closed a $5 million funding round. Switchboard plans to embed Livara’s MSK program directly into its automation platform. That platform focuses on referral management and care navigation. As a result, the deal expands Switchboard’s clinical capabilities. It also gives the combined entity fresh capital to speed deployment. Financial terms of the acquisition itself were not disclosed.
No Qualifying Deal Among Remaining Candidates: The rest of this week’s healthcare candidates did not fit this section. They included the Samaritan Health Services / MultiCare merger. That is an 18-hospital, $7.5B-revenue system combination, which counts as a large health-system deal. The list also held biopharma FDA approvals, AI scribe product launches, and workforce and regulatory stories. However, none meet the small-to-medium independent or group practice criteria. No additional qualifying named transactions were available in the sourced material this week.
Global Markets & Macro
Markets are navigating a tense mix of Fed policy uncertainty, Treasury intervention debate, and a pivotal earnings event. Meanwhile, Jackson Hole and a key inflation reading set the tone for the week.
Stocks and Treasuries Slip Ahead of Nvidia and PCE Data: U.S. equities struggled for direction, and Treasury prices eased. Traders pulled back from risk ahead of two major catalysts. The first is earnings from Nvidia. The second is July’s reading of the Federal Reserve’s preferred inflation gauge, the PCE index. The cautious mood shows how much weight markets place on both data points. Each is seen as a signal for the pace of future rate moves.
Bessent’s Bond Buybacks Put Treasury on Collision Course with Fed: A major flashpoint this week is the tension between Treasury Secretary Scott Bessent and Fed Chair Kevin Warsh. The Financial Times reports that increased Treasury purchases of debt threaten to undermine Warsh’s efforts to tame inflation. That dynamic has drawn sharp commentary from prominent investors. Morgan Stanley Investment Management’s Vishal Khanduja is described as a top-performing fixed-income investor. He disclosed he is scaling back bets against long-term U.S. bonds. He cited Bessent’s apparent readiness to do “whatever it takes” to keep yields from rising. Separately, Pimco’s Andrew Balls pointed to low volatility as a sign of a “healthy” bond market. Still, he said it is “not 100% clear” why the Treasury would increase purchases of long-dated bonds.
Gold Pulls Back as Jackson Hole Focus Sharpens: Gold retreated from a three-month high. Investors rotated attention toward the Federal Reserve’s annual Jackson Hole gathering. They are watching closely for the rate-path signals expected from it. The pullback followed a five-day rally. Inflation expectations and the upcoming PCE print are the key variables traders are watching.
Global Fuel Markets Under Pressure: Bloomberg flags that global fuel markets have “little margin for error.” The world is increasingly reliant on U.S. refineries that are operating near their limits. That strain adds an energy-cost dimension to the inflation picture. Central bankers at Jackson Hole will need to factor it into their guidance. In the U.K., household energy bills are set to hit a three-year high from October. The price cap will rise 4% to £1,723 per year, driven in part by Middle East conflict dynamics.
ECB Signals Further Rate Increases: On the European side, ECB Governing Council member Isabel Schnabel emphasized the need for further interest rate increases. She cited upside inflation risks. That hawkish signal aligns with the broader global central-bank tightening narrative heading into the Jackson Hole week.
What to Watch
For healthcare practice owners and advisors, the Switchboard-Livara deal carries a clear message. Value-based care and MSK platforms keep attracting both strategic buyers and venture capital, even as deal volume swings week to week. Employer healthcare costs are projected to rise as much as 9.2% in 2027. As a result, payers and plan sponsors will keep pressing providers on efficiency. That dynamic favors practices with demonstrable outcomes data. On the macro side, Nvidia’s earnings and the July PCE print will either validate or rattle the market’s fragile calm. A hotter-than-expected inflation reading could force the Fed’s hand on rates. Meanwhile, the Bessent-Warsh tension over Treasury buybacks adds a policy-coordination risk that markets have not fully priced. Overall, Jackson Hole guidance will be the week’s defining moment for rate-sensitive assets. It will also shape the financing conditions that underpin healthcare M&A activity heading into the fall.
Editorial note, image use & corrections. This report is compiled and summarized from publicly available news sources; figures and details should be independently verified. Accompanying images are used under Creative Commons or public-domain licenses (sourced via Openverse) and credited where required. If you believe any content — written or image — has been used in error, is inaccurate, or infringes your rights, or you wish to request a correction or removal, please contact us at info@tenetma.com and we will address it promptly.
Explore Tenet M&A
Tenet M&A helps physicians and practice owners navigate healthcare M&A. Start here:
- The Complete Guide to Selling a Medical Practice
- Medical Practice Valuation: What Is Your Practice Worth?
- Selling Your Medical Practice to Private Equity
Thinking about a sale? Learn about selling your medical practice, or start a confidential conversation.
What do these market moves mean for your practice value?
Get a confidential read on what your practice is worth in today's market.

